Gunduz S - Search Results

1

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Among authors: gunduz s. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.

2

Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer.

Tatli AM, Arslan D, Uysal M, Goksu SS, Gunduz SG, Coskun HS, Ozdogan M, Savas B, Bozcuk HS. Tatli AM, et al. J Cancer Res Ther. 2015 Oct-Dec;11(4):805-9. doi: 10.4103/0973-1482.146092. J Cancer Res Ther. 2015. PMID: 26881522 Free article.

3

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.

4

Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer.

Uysal M, Ozdogan M, Kargi A, Gunduz S, Sezgin Goksu S, Murat Tatli A, Arslan D, Mutlu H, Senol Coskun H, Bozcuk H. Uysal M, et al. Among authors: gunduz s. J BUON. 2014 Oct-Dec;19(4):980-4. J BUON. 2014. PMID: 25536605 Free article.

5

Hyperprogression after immunotherapy: A comprehensive review.

Okan Cakir M, Kirca O, Gunduz S, Ozdogan M. Okan Cakir M, et al. Among authors: gunduz s. J BUON. 2019 Nov-Dec;24(6):2232-2241. J BUON. 2019. PMID: 31983088 Free article. Review.

6

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.

Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S. Tural D, et al. Among authors: gunduz s. Eur Urol Focus. 2021 Sep;7(5):1061-1066. doi: 10.1016/j.euf.2020.09.010. Epub 2020 Sep 30. Eur Urol Focus. 2021. PMID: 33008789

7

Oral cyclophosphamide and etoposide in treatment of malignant pleural mesothelioma.

Gunduz S, Mutlu H, Goksu SS, Arslan D, Tatli AM, Uysal M, Coskun HS, Bozcuk H, Ozdogan M, Savas B. Gunduz S, et al. Asian Pac J Cancer Prev. 2014;15(20):8843-6. doi: 10.7314/apjcp.2014.15.20.8843. Asian Pac J Cancer Prev. 2014. PMID: 25374217 Free article.

8

Coexistence of gastric adenocarcinoma and choriocarcinoma: complete response to trastuzumab and chemotherapy.

Gunduz S, Elpek GO, Uysal M, Goksu SS, Tatli M, Arslan D, Coskun HS, Bozcuk H, Savas B, Ozdogan M. Gunduz S, et al. Case Rep Oncol. 2012 May;5(2):394-9. doi: 10.1159/000341662. Epub 2012 Jul 24. Case Rep Oncol. 2012. PMID: 23525369 Free PMC article.

9

Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab.

Uysal M, Bozcuk H, Sezgin Göksu S, Murat Tatli A, Arslan D, Gündüz S, Senol Coskun H, Ozdogan M, Savas B. Uysal M, et al. Among authors: gunduz s. Biomed Pharmacother. 2014 May;68(4):409-12. doi: 10.1016/j.biopha.2014.03.002. Epub 2014 Mar 18. Biomed Pharmacother. 2014. PMID: 24721326 Clinical Trial.

10

Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.

Arslan D, Bozcuk H, Gunduz S, Tural D, Tattli AM, Uysal M, Goksu SS, Bassorgun Cİ, Koral L, Coskun HS, Ozdogan M, Savas B. Arslan D, et al. Among authors: gunduz s. Asian Pac J Cancer Prev. 2014;15(6):2465-72. doi: 10.7314/apjcp.2014.15.6.2465. Asian Pac J Cancer Prev. 2014. PMID: 24761848 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page